Immunotherapy of diffuse gliomas: biological background, current status and future developments (Q37594831)

21 August 2017

1 reference

title

Immunotherapy of diffuse gliomas: biological background, current status and future developments (English)

1 reference

21 August 2017

1 reference

Oliver M Grauer

1 reference

21 August 2017

Pieter Wesseling

series ordinal

1 reference

21 August 2017

Gosse J Adema

series ordinal

1 reference

21 August 2017

publication date

1 October 2009

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

674-693

1 reference

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Brain dendritic cells and macrophages/microglia in central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

TLR ligands in the local treatment of established intracerebral murine gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Initiation of immune responses in brain is promoted by local dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Dendritic cells amplify T cell-mediated immune responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Systemic Immune Deviation in the Brain That Does Not Depend on the Integrity of the Blood-Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2009.00315.X

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE04753

Identifiers

DOI

10.1111/J.1750-3639.2009.00315.X

1 reference

21 August 2017

1 reference